ADVENT Sponsored Virtual Symposium

Exploring the Role of Type 2 Inflammation in Dermatologic Diseases

Date: Thursday 23 September 2021
Time: 18.30 – 19.30  CET

Mark Boguniewicz (USA) (Chair)
Ana Maria Giménez-Arnau (Spain)
Marcus Maurer (Germany)




18.30 – 18.32

Mark Boguniewicz (USA)

18.32 -18.47

The Role of Type 2 Inflammation in the Pathophysiology of Atopic Dermatitis
• Type 2 inflammation and barrier dysfunction: latest insights on AD pathophysiology

Mark Boguniewicz (USA)

18.47 – 19.02

Pruritic Dermatoses with a Type 2 Inflammation Component
• Type 2 pathophysiology in chronic spontaneous urticaria and prurigo nodularis

Marcus Maurer (Germany)

19.02 – 19.17

Type 2 Inflammation as a Therapeutic Target in Dermatologic Diseases
• Translational research perspective on clinical trial outcomes for agents targeting Type 2 inflammation

Ana Maria Giménez-Arnau (Spain)

19.17 – 19.30

Live Q&A

All Faculty

ADVENT is a medical education program for healthcare professionals organized by Sanofi Genzyme and
Regeneron. All faculty will be paid an honorarium for their participation in the event.
MAT-GLB-2102530 V2 June 2021
© 2021 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.